Showing results (51-60 of 337) with videos related to

Sort By:
Pageof 34
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 30, 2019
Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular CoagulationAmanda Walborn, Matthew Rondina, Michael Mosier, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|May 9, 2003
Factor Xa inhibitors: today and beyondJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 26, 2012
A comparison of the pharmacodynamic behavior of branded and biosimilar enoxaparin in primatesWalter Jeske, Evangelos Litinas, Hussein Khan, et al.
Hematology/Oncology Clinics of North America|March 12, 2003
Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiationDebra Hoppensteadt, Jeanine M Walenga, Jawed Fareed, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 7, 2012
Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal diseaseKorosh Sharain, Debra Hoppensteadt, Vinod Bansal, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Heparin to pentasaccharide and beyond: the end is not in sightHarry L Messmore, William H Wehrmacher, Erwin Coyne, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implicationNasiredin Sadeghi, Daniel Kahn, Walter Jeske, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 7, 2013
Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal diseaseKristiyana Kaneva, Vinod Bansal, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 18, 2019
Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular CoagulationPriya Patel, Amanda Walborn, Matthew Rondina, et al.
JACC. Case Reports|August 25, 2020
Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19Alexandru Marginean, Dalila Masic, Yevgeniy Brailovsky, et al.
Pageof 34